Banner_Prostate Cancer News

Low Rates of PSA Screening Linked to Increase in Metastatic Prostate Cancer

A study of men treated in Veterans Health Administration facilities suggested that lower prostate-specific antigen (PSA) screening rates were associated with subsequent increased rates of metastatic prostate cancer.

Vials with blood

Across 128 facilities, PSA screening rates declined from 47% in 2005 to 37% in 2019, which was observed across all ages and races, reported Brent S. Rose, MD, of the University of California San Diego, during a press briefing at the American Society for Radiation Oncology (ASTRO) annual meeting. The study was also published in JAMA Oncology.

Read the whole article here


source: Mike Bassett - Medpage Today

 

decorative background image

Read More About Prostate Cancer

Enjoy our library of additional news articles, our Journey to ZERO blog, and our ZEROHour newsletter.

Share